Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Single-Center Experience With Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma
Oncologist 2019 Dec 19;[EPub Ahead of Print], AJ Verschoor, FM Speetjens, PDS Dijkstra, M Fiocco, MAJ van de Sande, JVMG Bovée, H GelderblomFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.